Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Unimedic Aktiebolag
AB
Active
Org 5564267721
Storjordenvägen 2, 864 31
Matfors
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 1991 · 35 years old
86 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Unimedic Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
197M
148M
98M
49M
0M
2021: 96M
96M
2021
2022: 116M (+21% vs 2021)
116M
+21%
2022
2023: 158M (+36% vs 2022)
158M
+36%
2023
2024: 149M (-6% vs 2023)
149M
-6%
2024
2025: 140M (-6% vs 2024)
140M
-6%
2025
EBITDA
SEK millions
15M
9M
2M
-5M
-11M
2021: -6M
-6M
2021
2022: -4M (+33% vs 2021)
-4M
+33%
2022
2023: 10M (+350% vs 2022)
10M
+350%
2023
2024: 7M (-30% vs 2023)
7M
-30%
2024
2025: 4M (-43% vs 2024)
4M
-43%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
140 319
149 019
157 740
116 011
96 224
Staff expenses
—
—
—
—
—
EBITDA
4 021
7 276
9 659
−3 700
−6 054
Depreciation & amort.
−6 118
−7 751
−8 457
−8 348
−8 066
EBIT
−2 097
−475
1 202
−12 048
−14 120
Net financials
−3 961
−5 778
−3 552
5 859
−3 536
Profit before tax
−2 158
−4 938
−2 619
6 342
−3 431
Tax
−1
209
−250
−0
−73
Net profit
−2 159
−4 729
−2 869
6 342
−3 504
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
107 035
119 318
127 360
146 111
150 450
Equity
6 241
8 400
13 126
15 995
9 653
Long-term debt
57 608
57 608
57 608
57 608
52 428
Short-term debt
43 186
53 310
56 626
72 508
88 369
Total debt
100 794
110 918
114 234
130 116
140 797
Financial ratios
5-year trend
EBITDA margin
2,9 %
This company
15,8 %
Market median
This company
Market median
82% below market
2021
2025
Equity ratio
5,8 %
This company
38,2 %
Market median
This company
Market median
85% below market
2021
2025
Return on equity
−34,6 %
This company
18,4 %
Market median
This company
Market median
288% below market
2021
2025
Net profit margin
−1,5 %
This company
8,1 %
Market median
This company
Market median
119% below market
2021
2025
Asset turnover
1,31×
This company
1,12×
Market median
This company
Market median
17% above market
2021
2025
Debt / equity
16,15×
This company
0,62×
Market median
This company
Market median
>999% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Unimedic Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
